Back 27 Jun 2025

Tianjin Da Ren Tang Completes RMB1.62 Billion Disposal of Final 12% Stake in Tianjin TSKF to Haleon

Link: https://links.sgx.com/1.0.0/corporate-announcements/UWCIVSMQ9XJOMHKU/9ef8c0977ee8ebbe803c02d480d6b7d93fe5e4300cddd1bf7e23dcfca58721a2

Summary:

  • Tianjin Pharmaceutical Da Ren Tang Group has completed the sale of its remaining 12% equity stake in Tianjin TSKF Pharmaceutical Co., Ltd.

  • The stake was sold to Haleon China Co., Ltd. and Haleon CH SARL for a total consideration of RMB1.62 billion.

  • Industrial and commercial registration formalities for the disposal have been completed.

  • Following this transaction, the company no longer holds any equity in Tianjin TSKF.

  • The disposal was approved by shareholders at the EGM on 9 June 2025.